2019
DOI: 10.1080/2326263x.2019.1655837
|View full text |Cite
|
Sign up to set email alerts
|

Increasing brain-computer interface media depictions: pressing ethical concerns

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(15 citation statements)
references
References 34 publications
0
15
0
Order By: Relevance
“…745-746). A recent study by Gilbert et al (2019) confirms this insight, reveal-3 A Neuralink progress update, live streamed to YouTube last summer, shows that the technology has already been successfully embedded into the brains of pigs (Neuralink, 2020). iJournal, Vol 6, No.…”
Section: Philosophical Implications Of the Wired Brainmentioning
confidence: 89%
“…745-746). A recent study by Gilbert et al (2019) confirms this insight, reveal-3 A Neuralink progress update, live streamed to YouTube last summer, shows that the technology has already been successfully embedded into the brains of pigs (Neuralink, 2020). iJournal, Vol 6, No.…”
Section: Philosophical Implications Of the Wired Brainmentioning
confidence: 89%
“…Many scientific articles have recently discussed the need for more regulation of neurotechnologies, painting a rather threatening picture of neurotechnology developments [47,48]. However, a recently conducted media review shows quite the opposite [49]. The authors report that mass media portrays BCI technology in an overly positive and enthusiastic manner, including little negative or critical aspects and almost lacking any ethical discussion.…”
Section: Discussionmentioning
confidence: 99%
“…It may downplay other significant risks to trial participants due to the unknown impact of the treatment. Futhermore, as observed with other experimental invasive technologies [13], positive reporting of a clinical trial in mainstream media often ignores the risks and unproven nature of the treatment which may further bias participants' view of their inclusion. It is critical that risks associated with participation in an optogenetics trial (i.e.…”
Section: Key Messagesmentioning
confidence: 99%